Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tests for Cushing's syndrome.

Lynnette K Nieman1

  • 1Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development/NIH, Building 10, Room 9D42, 10 Center Drive MSC 1583, Bethesda, MD 20892, USA. NiemanL@nih.gov

Annals of the New York Academy of Sciences
|October 17, 2002
PubMed
Summary

This study focuses on how to accurately diagnose Cushing's syndrome, a condition caused by high cortisol levels. It explains that while typical symptoms like weight gain and skin changes are clear indicators, some patients with similar symptoms do not have the disease. These cases are called pseudo-Cushing states and are linked to other conditions like psychiatric disorders or obesity. The study highlights the importance of using additional tests like midnight cortisol measurements and dexamethasone suppression tests to confirm true Cushing's syndrome. These tests help avoid misdiagnosis and ensure accurate identification of the condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aligning treatment to physiology: when to use chronotherapy, block and replace, or titration to treat hypercortisolism.

Journal of the Endocrine Society·2026
Same author

Artificial Intelligence-Based Approach for Automated Gonad Volume Quantification Using Magnetic Resonance Imaging in Healthy Adolescents Across Puberty.

Diagnostics (Basel, Switzerland)·2026
Same author

The interplay between loneliness, cortisol, and NK cell function: The role of cortisol in NK cell dysfunction.

Psychoneuroendocrinology·2026
Same author

Phosphoproteomic dysregulation drives tumor proliferation in Cushing's disease.

bioRxiv : the preprint server for biology·2025
Same author

Unmasking Hypercortisolism in Difficult-to-Control Type 2 Diabetes: A Useful Paradigm Shift?

Diabetes care·2025
Same author

Diagnosis of Cushing's Disease.

Endocrinology and metabolism clinics of North America·2025

Area of Science:

  • Endocrinology diagnostic protocols
  • Clinical biochemistry testing
  • Hormonal disorder diagnostics

Background:

Established clinical guidelines already identify key signs of Cushing's syndrome, such as weight gain and skin changes. These features are often sufficient for diagnosis when combined with high cortisol levels in urine. However, some patients show similar symptoms without true hypercortisolism. This overlap can lead to misdiagnosis in individuals with psychiatric or metabolic conditions. Current research has not fully resolved how to distinguish true Cushing's syndrome from pseudo-Cushing states. This uncertainty motivates the need for additional diagnostic tools. Patients with mild cortisol elevations may be misclassified due to shared symptoms. The challenge lies in identifying those with true disease versus those with benign conditions. This diagnostic gap remains a focus for clinical research.

Purpose Of The Study:

The aim of this work is to clarify the diagnostic process for Cushing's syndrome. It addresses the issue of overlapping symptoms between true cases and pseudo-Cushing states. The study focuses on how to differentiate between these two groups. It highlights the limitations of standard tests like 24-hour urine cortisol. The motivation stems from the risk of misdiagnosis in patients with similar presentations. The goal is to improve accuracy in diagnosing true Cushing's syndrome. This involves evaluating additional tests beyond initial screening. The study emphasizes the importance of follow-up assessments for ambiguous cases.

Keywords:
Cushing's syndrome testingdexamethasone suppression testcortisol measurement methodsendocrine disorder diagnostics

Frequently Asked Questions

The study shows that 24-hour urine free cortisol more than four times normal confirms Cushing's syndrome.

The 2-day-2-mg dexamethasone suppression test is recommended for confirmation in ambiguous cases.

Midnight cortisol measurements detect abnormal cortisol secretion patterns missed by other tests.

This test provides additional diagnostic value by assessing cortisol suppression in response to CRH.

Related Experiment Videos

Main Methods:

The diagnostic approach involves a combination of clinical evaluation and biochemical testing. Initial assessments include observing typical signs like truncal obesity and striae. Urine free cortisol levels are measured to confirm hypercortisolism. Patients with ambiguous symptoms require further testing for clarification. Midnight cortisol measurements are used to detect abnormal cortisol secretion. The 2-day-2-mg dexamethasone suppression test is employed to assess cortisol suppression. The dexamethasone suppression-CRH stimulation test is used for confirmation. These methods help distinguish true Cushing's syndrome from pseudo-Cushing states.

Main Results:

The strongest finding is that 24-hour urine free cortisol excretion more than four times normal confirms Cushing's syndrome. Patients with typical clinical features and high cortisol levels have a clear diagnosis. Those with non-specific symptoms often have normal cortisol excretion. Pseudo-Cushing states are linked to psychiatric or metabolic conditions. Midnight cortisol measurements improve diagnostic accuracy in ambiguous cases. The 2-day-2-mg dexamethasone suppression test is effective in confirming true disease. The dexamethasone suppression-CRH stimulation test provides additional diagnostic value. These tests help avoid misdiagnosis in patients with overlapping symptoms.

Conclusions:

The authors emphasize that clinical features and cortisol levels are essential for diagnosis. They propose that additional tests are necessary for patients with non-specific symptoms. The 2-day-2-mg dexamethasone suppression test is recommended for confirmation. Midnight cortisol measurements are useful in identifying true Cushing's syndrome. The dexamethasone suppression-CRH stimulation test is proposed as a supplementary tool. These findings suggest that multiple tests are needed for accurate diagnosis. The authors suggest that follow-up assessments improve diagnostic clarity. These conclusions are based on the evidence presented in the study.

The study uses follow-up tests like midnight cortisol and dexamethasone suppression to distinguish true cases.

The authors propose that multiple tests are needed to avoid misdiagnosis in patients with overlapping symptoms.